home / stock / nlbif / nlbif news

NLBIF News and Press, New Age Brands From 10/07/20

Stock Information
Company Name: New Age Brands
Stock Symbol: NLBIF
Market: OTC
Menu
NLBIF NLBIF Quote NLBIF Short NLBIF News NLBIF Articles NLBIF Message Board
Get NLBIF Alerts

News, Short Squeeze, Breakout and More Instantly...
NLBIF - Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin

VANCOUVER, British Columbia, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) ("Mydecine" or the "Company"), is pleased to announce its wholly-owned subsidiary, NeuroPharm Inc. ("NeuroPharm”), has filed a provisional patent applicat...
NLBIF - Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today

DENVER, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc., ( CSE:MYCO ) ( OTC:MYCOF ) ( FSE:0NFA ) ("Mydecine" or the "Company") is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital telehealth mobile appli...

NLBIF - Mindleap Health Announces The Launch of The World's First Telehealth Platform For Psychedelic Integration

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/42c4893d-6232-4d13-9d58-b3098cc222bb DENVER, Sept. 24, 2020 (GLOBE NEWSWIRE) --  Mydecine Innovations Group Inc. ( MYCO.CN ) ( MYCOF ) ( 0NF.F ) ("...

NLBIF - Mindleap Health Implements HIPAA Compliance Standards and Appoints Former Canadian Ministry of Health Telemedicine Expert as Head of Program Management

DENVER, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc. (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), is pleased to announce that its wholly-owned subsidiary, Mindleap Health (“Mindleap”), has implemented a comprehensive informatio...
NLBIF - Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets

DENVER, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" or the "Company"), today announced the Company has formed a special committee to evaluate a number of options to increase shareholders value. Topics that the special c...

NLBIF - Mydecine Innovations Group Would Like to Give Thanks to its Shareholders for Extending the Lockup on the Five Cent Placement for Another 120 Days

DENVER, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine", “MIG” or the "Company") is pleased to announce that its shareholders have agreed to extend lock-up restrictions in respect to 35,737,460 shares of th...

NLBIF - Mydecine Innovations Group Announces Extended Lock-Up Arrangement

DENVER, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. ( CSE:MYCO ) ( OTC:MYCOF ) ( FSE:0NFA ) ("Mydecine" or the "Company"), today announced that it has engaged with certain shareholders to enter into voluntary lock-up agreements (the “Lock-up Agreements...
NLBIF - Mydecine(TM) Launches World's First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise

DENVER, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine™" or the "Company") is pleased to announce it is the first organization to exercise its cGMP(₁) capabilities under a special license to legally produce,...

NLBIF - Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD

DENVER, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" or the "Company"), is pleased to announce that NeuroPharm Inc., a company focused on developing unique mental health therapies and approaches for veteran wellness, was...

NLBIF - Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector

DENVER, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) ("Mydecine" “MIG” or the "Company"), is pleased to provide a corporate update regarding recent advancements and achievements that continues to add shareholder value and ...
Previous 10 Next 10